Search

Author/Creator Fox, David A.

11. Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma. Issue 8 (15th April 2017)

Authors:
Hutchings, Kim M.; Lisabeth, Erika M.; Rajeswaran, Walajapet; Wilson, Michael W.; Sorenson, Roderick J.; Campbell, Phillip L.; Ruth, Jeffrey H.; Amin, Asif; Tsou, Pei-Suen; Leipprandt, Jeffrey R.; Olson, Samuel R.; Wen, Bo; Zhao, Ting; Sun, Duxin; Khanna, Dinesh; Fox, David A.; Neubig, Richard R....
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 27:Issue 8(2017)
Page Start:
1744
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease. Issue 8 (17th August 2017)

Authors:
Totzke, Juliane; Gurbani, Deepak; Raphemot, Rene; Hughes, Philip F.; Bodoor, Khaldon; Carlson, David A.; Loiselle, David R.; Bera, Asim K.; Eibschutz, Liesl S.; Perkins, Marisha M.; Eubanks, Amber L.; Campbell, Phillip L.; Fox, David A.; Westover, Kenneth D.; Haystead, Timothy A.J.; Derbyshire, E...
Journal:
Cell chemical biology
Issue:
Volume 24:Issue 8(2017)
Page Start:
1029
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗